The White House updated its “Make America Healthy Again” report on childhood chronic disease after facing scrutiny from experts over the apparent use of artificial intelligence to generate citations, The Washington Post reported May 29. Of the 522 citations in the initial report with links to articles or studies, at least 21 were dead and […]
At the 15mg dose, participants showed a sustained average weight loss of 22.9% during the three-year treatment. Credit: SB Arts Media / Shutterstock. Eli Lilly has reported comprehensive outcomes from the SURMOUNT-1 study of tirzepatide (Zepbound and Mounjaro) for treating pre-diabetic and obese individuals. Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy […]
Radella Pharmaceuticals’ MD-18 shows promise in Phase 1a results. (Credit: Bruno from Pixabay) Radella Pharmaceuticals, a clinical-stage biopharmaceutical company, has announced topline results from its Phase 1a study of MD-18, an investigational treatment for obesity and diabetes. The study evaluated MD-18’s safety, tolerability, and pharmacokinetics. MD-18 targets protein-tyrosine phosphatase 1B (PTP1B), a therapeutic target supporting […]
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $0.38 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 16.28%. A quarter ago, […]
Tandem Diabetes Care ( (TNDM) ) has released its Q3 earnings. Here is a breakdown of the information Tandem Diabetes Care presented to its investors. Tandem Diabetes Care is a global company specializing in insulin delivery and diabetes technology, known for its advanced automated insulin delivery systems, including the Tandem Mobi and t:slim X2 pumps […]
Welcome to Herbology News!
At Herbology News, we’re dedicated to empowering you with knowledge and resources to help you lead a healthier life naturally.
Herbologynews @2024. All Rights Reserved.
Subscribe to receive fresh content, tips, and insights delivered straight to your inbox—never miss a post again!
